These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5788367)

  • 21. [Morphological changes in the stomach in portocaval anastomosis in dogs].
    Rudenskaia MV
    Eksp Khir Anesteziol; 1967; 12(2):34-8. PubMed ID: 5618922
    [No Abstract]   [Full Text] [Related]  

  • 22. [Relationship between the effect of exogenous histamine on gastric secretion and in indices of endogenous histamine metabolism].
    Geller LI; Kozlova AP
    Lab Delo; 1971; 4():212-4. PubMed ID: 4108211
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased gastric synthesis of histamine: a possible mechanism for the gastric acid hypersecretion following portacaval shunt.
    Fischer JE; Snyder SH
    Fed Proc; 1965; 24(6):1334-40. PubMed ID: 5322507
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure to pentagastrin administration to restore postprandial acid secretion from Heidenhain pouches after antrectomy in dogs.
    Keuppens F; Bremen J; Woussen-Colle MC; De Graef J
    Surgery; 1976 Nov; 80(5):586-90. PubMed ID: 982276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric acid secretion and mucosal blood flow in the rabbit [proceedings].
    Curwain BP; Turner NC
    J Physiol; 1980 Jan; 298():2P-3P. PubMed ID: 7359390
    [No Abstract]   [Full Text] [Related]  

  • 26. Intestinal phase of gastric acid secretion: augmentation of maximal response of Heidenhain pouch to gastrin and histamine.
    Debas HT; Slaff GF; Grossman MI
    Gastroenterology; 1975 Apr; 68(4 Pt 1):691-8. PubMed ID: 1123137
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastrin inhibition of gastric secretion before and after portacaval shunt.
    Wilken BJ; Hunt D; Lowe CF; Billups WA; Hardy JD
    Surg Gynecol Obstet; 1969 Jul; 129(1):22-6. PubMed ID: 4389307
    [No Abstract]   [Full Text] [Related]  

  • 28. Gastric secretion study on dogs continuously perfused with histamine.
    Cannata B; Alonso A; Zeolite C; Born R; Figueroa E; Suárez JR
    Acta Gastroenterol Latinoam; 1970; 2(4):199-202. PubMed ID: 4946817
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of histalog and histamine as stimulants for maximal gastric secretion in human subjects and in dogs.
    Ward S; Gillespie IE; Passaro EP; Grossman MI
    Gastroenterology; 1968 Apr; 54(4):Suppl:711-3. PubMed ID: 5653776
    [No Abstract]   [Full Text] [Related]  

  • 30. Gastric secretion in the chronic fistula ferret.
    Pfeiffer CJ; Peters CM
    Gastroenterology; 1969 Nov; 57(5):518-24. PubMed ID: 5348086
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum gastrin, gastrointestinal tissue gastrin, gastric hypersecretion after portacaval shunt in rats.
    Reichle FA; Reeder DD; Reichle RM; Thompson JC
    Surg Forum; 1974; 25(0):418-20. PubMed ID: 4439213
    [No Abstract]   [Full Text] [Related]  

  • 32. Some observations on the cause of the gastric hypersecretion following portacaval shunt.
    McPhedran NT; Bett HD; Stone RM; Goldberg M
    Bull Soc Int Chir; 1968; 27(4):286-90. PubMed ID: 5714998
    [No Abstract]   [Full Text] [Related]  

  • 33. Action of the pentapeptide (ICI 50123) on gastric secretion in man.
    Makhlouf GM; McManus JP; Card WI
    Gastroenterology; 1968 Apr; 54(4):Suppl:727-8. PubMed ID: 5653782
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the problem of maximal gastric acid secretion in the rat].
    Schmidt HA; Bock H; Riecken EO
    Arzneimittelforschung; 1970 Oct; 20(10):1510-3. PubMed ID: 4098165
    [No Abstract]   [Full Text] [Related]  

  • 35. Proceedings: The intestinal phase of gastric secretion in the dog.
    Cairns D; Deveney CW; Way LN
    Gut; 1975 May; 16(5):406. PubMed ID: 1140682
    [No Abstract]   [Full Text] [Related]  

  • 36. [Quantitative study of gastric acid-peptic secretion by vagal or humoral stimulation].
    Mazure PA; Parodi H; Waisman R; Babot B
    Acta Gastroenterol Latinoam; 1972; 4(2):49-56. PubMed ID: 4566076
    [No Abstract]   [Full Text] [Related]  

  • 37. Quantitative statement of the two-component hypothesis.
    Demand HA
    Gastroenterology; 1968 Apr; 54(4):674-6. PubMed ID: 5652516
    [No Abstract]   [Full Text] [Related]  

  • 38. Nature of the gastric hypersecretion associated with intestinal exclusion.
    Villar H; Abbott AG; Williams RJ; Rosen H; Orloff MJ
    Surg Forum; 1971; 22():299-300. PubMed ID: 5121380
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence that the inhibitory effect of burimamide on gastric secretion is not due to decreased gastric mucosal blood flow.
    Curwain BP; Holton P; Spencer J
    J Physiol; 1973 Apr; 230(1):33P-34P. PubMed ID: 4702436
    [No Abstract]   [Full Text] [Related]  

  • 40. [Xylamide, a new drug with specific activity in hypersecretion and in metabolic changes of the gastric mucosa].
    Rovati AL; Borellini D
    Arch Ital Mal Appar Dig; 1969; 36(1):60-8. PubMed ID: 5405274
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.